MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, ALGS has $88,533K in assets. $34,988K in debts. $18,303K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
390.25%
Quick Ratio
390.25%
Cash Ratio
86.20%
Debt to Asset Ratio
39.52%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Accumulated depreciation
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • 2023 common warrants liability
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
18,303
Restricted cash
110
Short-term investments
59,541
Other current assets
4,908
Total current assets
82,862
Operating lease right-of-use assets
3,089
Total, at cost
14,579
Accumulated depreciation
12,712
Property and equipment, net
1,867
Other assets
715
Total assets
88,533
Accounts payable
3,982
Accrued liabilities
13,526
Operating lease liabilities, current
3,580
Finance lease liabilities, current
145
Deferred revenue, current
0
Total current liabilities
21,233
Operating lease liabilities, net of current portion
1,525
Finance lease liabilities, net of current portion
0
2023 common warrants liability
12,183
Long term liability
47
Total liabilities
34,988
Common stock, 0.0001 par value 115,800,000 shares and 20,800,000 shares authorized as of december 31, 2025 and december 31, 2024, respectively 6,178,230 and 3,864,436 shares issued and outstanding as of december 31, 2025 and december 31, 2024, respectively
9
Additional paid-in capital
695,269
Accumulated deficit
-642,201
Accumulated other comprehensive income
468
Total stockholders' equity (deficit)
53,545
Total liabilities and stockholders' equity (deficit)
88,533
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$59,541K Cash and cashequivalents$18,303K Other current assets$4,908K Restricted cash$110K Total, at cost$14,579K Total current assets$82,862K Operating leaseright-of-use assets$3,089K Property and equipment,net$1,867K Other assets$715K Accumulated depreciation$12,712K Total assets$88,533K Total liabilities andstockholders' equity...$88,533K Total stockholders'equity (deficit)$53,545K Total liabilities$34,988K Accumulated deficit-$642,201K Additional paid-in capital$695,269K Total currentliabilities$21,233K 2023 common warrantsliability$12,183K Operating leaseliabilities, net of current...$1,525K Long term liability$47K Accumulated othercomprehensive income$468K Common stock, 0.0001par value...$9K Accrued liabilities$13,526K Accounts payable$3,982K Operating leaseliabilities, current$3,580K Finance leaseliabilities, current$145K

Aligos Therapeutics, Inc. (ALGS)

Aligos Therapeutics, Inc. (ALGS)